Quoin Pharmaceuticals (QNRX) Stock Statistics & Valuation Metrics

Quoin Pharmaceuticals has a market cap or net worth of $10.52M. The enterprise value is -$3.81B.

Quoin Pharmaceuticals has 1,803,626 shares outstanding. The number of shares has decreased by -2.65% in one year.

Quoin Pharmaceuticals’s return on equity (ROE) is -1.20K and return on invested capital (ROIC) is -0.11%.

The current PE Ratio of Quoin Pharmaceuticals is ―. Quoin Pharmaceuticals’s PEG ratio is >-0.00001.

In the last 12 months, Quoin Pharmaceuticals had revenue of 0.00 and earned -15.80B in profits. Earnings per share was -14.80K.

In the last 12 months, operating cash flow was -13.59M and capital expenditures 4.00, giving a free cash flow of -13.59M billion.

Quoin Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Quoin Pharmaceuticals upcoming earnings date is May 13, 2026, Before Open (Confirmed).

Quoin Pharmaceuticals as a current ratio of 3.61, with Debt / Equity ratio of 0.00%

In the past 12 months, Quoin Pharmaceuticals has paid 0.00 in taxes.

Quoin Pharmaceuticals EV to EBITDA ratio is 233.02, with an EV/FCF ratio of 0.28.

Quoin Pharmaceuticals has $3.82B in cash and marketable securities with $0.00 in debt, giving a net cash position of $3.82B billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Quoin Pharmaceuticals is $37.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy